Itau Unibanco Holding S.A.’s Karyopharm Therapeutics KPTI Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-96	Closed	-$9K	–	937
2019 Q3	$9K	Hold	96	–	–	﹤0.01%	285
2019 Q2	$9K	Sell	96 -80	-45%	-$6.42K	﹤0.01%	588
2019 Q1	$24K	Hold	176	–	–	﹤0.01%	561
2018 Q4	$24K	Buy	176 +3	+2%	+$506	﹤0.01%	561
2018 Q3	$44K	Sell	173 -5	-3%	-$1.38K	﹤0.01%	550
2018 Q2	$45K	Sell	178 -55	-24%	-$13.6K	﹤0.01%	624
2018 Q1	$47K	Buy	233 +169	+264%	+$33.7K	﹤0.01%	482
2017 Q4	$9K	Buy	64 +8	+14%	+$1.28K	﹤0.01%	525
2017 Q3	$29K	Sell	56 -137	-71%	-$19.6K	﹤0.01%	606
2017 Q2	$26K	Buy	193 +174	+916%	+$25.8K	﹤0.01%	380
2017 Q1	$4K	Buy	+19	New	+$3.05K	﹤0.01%	654

Other funds holding KPTI

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Itau Unibanco Holding S.A.'s KPTI Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Karyopharm Therapeutics (KPTI) in Q4 2019, closing a stake of 96 shares — an estimated $9K sold.

Itau Unibanco Holding S.A. first reported a position in KPTI in Q1 2017 and held it in 11 quarters. The position peaked at $47K in Q1 2018. 146 funds tracked by Wall St. Rank hold KPTI as of Q4 2019.

Itau Unibanco Holding S.A. reported no remaining Karyopharm Therapeutics position as of Q4 2019 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 96 Karyopharm Therapeutics shares in Q4 2019, an estimated $9K.
Itau Unibanco Holding S.A. first reported a position in Karyopharm Therapeutics in Q1 2017 and held it in 11 quarters.
Itau Unibanco Holding S.A.'s Karyopharm Therapeutics position peaked at $47K in Q1 2018.
146 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.